These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 206381)

  • 1. [Receptors for vasoactic intestinal peptide (VIP) in human colonic adenocarcinoma membranes: specific binding and stimulation of adenylate cyclase].
    Dupont C; Amiranoff B; Laburthe M; Rosselin G
    C R Acad Hebd Seances Acad Sci D; 1978 Jan; 286(2):209-12. PubMed ID: 206381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasoactive intestinal peptide (VIP): specific receptors and adenylate cyclase activation in a human prolactin-secreting pituitary tumor].
    Bataille D; Peillon F; Besson J; Rosselin G
    C R Seances Acad Sci D; 1979 May; 288(17):1315-7. PubMed ID: 225051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J; Waelbroeck M; Chatelain P; Robberecht P
    Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol ester induces loss of VIP stimulation of adenylate cyclase and VIP-binding sites in HT29 cells.
    Bozou JC; Couvineau A; Rouyer-Fessard C; Laburthe M; Vincent JP; Kitabgi P
    FEBS Lett; 1987 Jan; 211(2):151-4. PubMed ID: 3026847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
    Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29.
    Turner JT; Jones SB; Bylund DB
    Peptides; 1986; 7(5):849-54. PubMed ID: 3025826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes.
    Dharmsathaphorn K; Harms V; Yamashiro DJ; Hughes RJ; Binder HJ; Wright EM
    J Clin Invest; 1983 Jan; 71(1):27-35. PubMed ID: 6294141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
    Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
    Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
    Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
    Prieto JC; Guerrero JM; de Miguel C; Goberna R
    Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts.
    Beed EA; O'Dorisio MS; O'Dorisio TM; Gaginella TS
    Regul Pept; 1983 Apr; 6(1):1-12. PubMed ID: 6306732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
    Charlton BG; Neal DE; Simmons NL
    J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
    Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of the hormone receptor for vaso-intestinal peptide to an adenylate cyclase system in another cell.
    Laburthe M; Rosselin G; Rousset M; Zweibaum A; Korner M; Selinger Z; Schramm M
    FEBS Lett; 1979 Feb; 98(1):41-3. PubMed ID: 218842
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
    Broyart JP; Dupont C; Laburthe M; Rosselin G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of guanine nucleotides on the first step of VIP and glucagon action in membranes from liver cells.
    Amiranoff B; Laburthe M; Rosselin G
    Biochem Biophys Res Commun; 1980 Sep; 96(1):463-8. PubMed ID: 6254514
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes.
    Robberecht P; Waelbroeck M; Camus JC; De Neef P; Christophe J
    Biochim Biophys Acta; 1984 Jun; 773(2):271-8. PubMed ID: 6329286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
    Juarranz MG; De Neef P; Robberecht P
    Prostate; 1999 Sep; 41(1):1-6. PubMed ID: 10440869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.